Park MS - Search Results

1

Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins.

Park MS, Shaw ML, Muñoz-Jordan J, Cros JF, Nakaya T, Bouvier N, Palese P, García-Sastre A, Basler CF. Park MS, et al. J Virol. 2003 Jan;77(2):1501-11. doi: 10.1128/jvi.77.2.1501-1511.2003. J Virol. 2003. PMID: 12502864 Free PMC article.

2

Newcastle disease virus V protein is a determinant of host range restriction.

Park MS, García-Sastre A, Cros JF, Basler CF, Palese P. Park MS, et al. J Virol. 2003 Sep;77(17):9522-32. doi: 10.1128/jvi.77.17.9522-9532.2003. J Virol. 2003. PMID: 12915566 Free PMC article.

3

Syncytia induction enhances the oncolytic potential of vesicular stomatitis virus in virotherapy for cancer.

Ebert O, Shinozaki K, Kournioti C, Park MS, García-Sastre A, Woo SL. Ebert O, et al. Among authors: park ms. Cancer Res. 2004 May 1;64(9):3265-70. doi: 10.1158/0008-5472.can-03-3753. Cancer Res. 2004. PMID: 15126368

4

Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors.

Nakaya Y, Nakaya T, Park MS, Cros J, Imanishi J, Palese P, García-Sastre A. Nakaya Y, et al. Among authors: park ms. J Virol. 2004 Sep;78(17):9366-75. doi: 10.1128/JVI.78.17.9366-9375.2004. J Virol. 2004. PMID: 15308731 Free PMC article.

5

Mapping of the RNA promoter of Newcastle disease virus.

Marcos F, Ferreira L, Cros J, Park MS, Nakaya T, García-Sastre A, Villar E. Marcos F, et al. Among authors: park ms. Virology. 2005 Jan 20;331(2):396-406. doi: 10.1016/j.virol.2004.10.040. Virology. 2005. PMID: 15629782 Free article.

6

Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease.

Park MS, Steel J, García-Sastre A, Swayne D, Palese P. Park MS, et al. Proc Natl Acad Sci U S A. 2006 May 23;103(21):8203-8. doi: 10.1073/pnas.0602566103. Epub 2006 May 22. Proc Natl Acad Sci U S A. 2006. PMID: 16717196 Free PMC article.

7

Influenza virus evades innate and adaptive immunity via the NS1 protein.

Fernandez-Sesma A, Marukian S, Ebersole BJ, Kaminski D, Park MS, Yuen T, Sealfon SC, García-Sastre A, Moran TM. Fernandez-Sesma A, et al. Among authors: park ms. J Virol. 2006 Jul;80(13):6295-304. doi: 10.1128/JVI.02381-05. J Virol. 2006. PMID: 16775317 Free PMC article.

8

Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus.

Vigil A, Park MS, Martinez O, Chua MA, Xiao S, Cros JF, Martínez-Sobrido L, Woo SL, García-Sastre A. Vigil A, et al. Among authors: park ms. Cancer Res. 2007 Sep 1;67(17):8285-92. doi: 10.1158/0008-5472.CAN-07-1025. Cancer Res. 2007. PMID: 17804743

9

Expression of transgenes from newcastle disease virus with a segmented genome.

Gao Q, Park MS, Palese P. Gao Q, et al. Among authors: park ms. J Virol. 2008 Mar;82(6):2692-8. doi: 10.1128/JVI.02341-07. Epub 2008 Jan 16. J Virol. 2008. PMID: 18199643 Free PMC article.

10

Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells.

Leung LW, Park MS, Martinez O, Valmas C, López CB, Basler CF. Leung LW, et al. Among authors: park ms. Immunol Cell Biol. 2011 Oct;89(7):792-802. doi: 10.1038/icb.2010.169. Epub 2011 Jan 25. Immunol Cell Biol. 2011. PMID: 21263462 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,299 results

Search Page

Filters